![AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio](/i/c/34a1ef7d-8312-80a4-62b1-995c961070a3.webp)
AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio
AbbVie said on Thursday it will buy drugmaker ImmunoGen for $10.1 billion, boosting its presence in the market
2023-11-30 20:48
![AbbVie trims full-year profit forecast on higher R&D expenses](/i/c/d14772f5-f70f-629a-5c79-5cdbe30fe8af.webp)
AbbVie trims full-year profit forecast on higher R&D expenses
(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development
2023-07-07 05:20